Clinical Trials Directory

Trials / Sponsors / Bharat Biotech International Limited

Bharat Biotech International Limited

Industry · 19 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingSafety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolesce
Tuberculosis (TB)
Phase 22025-03-01
CompletedTuberculosis Vaccine in Healthy Indian Adults
Tuberculosis
Phase 12024-01-19
Active Not RecruitingThe Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
Rotavirus Infection of Children
Phase 32023-07-07
UnknownTo Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)
Cholera
Phase 32023-02-04
UnknownPhase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers
COVID-19 Respiratory Infection
Phase 32022-04-16
CompletedPhase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose
COVID-19 Respiratory Infection
Phase 32022-02-26
UnknownA Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiori
Cholera
Phase 32022-02-22
CompletedBBV152/BBV154 Heterologus Prime-Boost Study
Corona Virus Infection
Phase 22021-09-01
CompletedCOVAXIN in a Pediatric Cohort
SARS-CoV2 Infection
Phase 2 / Phase 32021-05-26
CompletedSafety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19
SARS-CoV Infection
Phase 12021-03-01
UnknownAn Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers
Covid19, SARS-CoV Infection
Phase 32020-11-16
CompletedWhole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers
COVID-19, SARS-CoV-2 Infection
Phase 1 / Phase 22020-07-15
CompletedEvaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam
Rotavirus Gastroenteritis
Phase 32017-12-20
CompletedSafety and Immunogenicity of BBV121
Zika Virus Infection
Phase 12017-06-03
CompletedClinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine
Chikungunya
Phase 12017-04-17
CompletedTo Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavir
Rotavirus Gastroenteritis
Phase 32015-03-20
UnknownA Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV)
Viral Gastroenteritis Due to Rotavirus
Phase 32011-03-01
CompletedA Trial Using Double-Bolus THR-100 Versus Streptokinase
Acute Myocardial Infarction
Phase 32010-10-01
CompletedDose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks
Diarrhea
Phase 1 / Phase 22006-12-01